Paper31495604
Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid.
Takousis P and 8 others. Alzheimers Dement, 2019. Cited by 142 papers, by iCite.
Cite this record
ConductScience Library. Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid. Papers, record 31495604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31495604
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Biomarkers | Major topic |
| MicroRNAs | Major topic |
| Brain | |
| Case-Control Studies | |
| Epigenomics | |
| Humans |
Source PubMed
Cited by108
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 142 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42538997 | MicroRNA-223 Enhances Microglia-Dependent Clearance of Amyloid Beta Plaques and Ameliorates Behavioral Deficits in a Mouse Model of Alzheimer's Disease. | bioRxiv | 2026 | https://conductscience.org/library/papers/42538997 | PubMed |
| 42450256 | Peripheral and Central miRNA Signatures in Alzheimer's Disease: Tissue-Specific Variability, Sex-Associated Differences, and Implications for Blood-Based Biomarkers. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450256 | PubMed |
| 42368021 | MicroRNA-181 influences Alzheimer's risk by regulating neprilysin and microtubule-associated tau pathways, offering a novel target. | bioRxiv | 2026 | https://conductscience.org/library/papers/42368021 | PubMed |
| 42062542 | The role of microRNAs in executive functions: a comprehensive review and bioinformatics analysis of human and animal studies. | Mol Psychiatry | 2026 | https://conductscience.org/library/papers/42062542 | PubMed |
| 42056645 | Electrochemical detection of miRNA-128 in Alzheimer's disease using (3-aminopropyl) triethoxysilane and citrate-capped green-synthesized silver nanoparticles. | Mikrochim Acta | 2026 | https://conductscience.org/library/papers/42056645 | PubMed |
| 42032299 | Blood-derived microRNA signatures associated with hippocampal structure and atrophy rate: findings from the Rhineland Study. | Mol Psychiatry | 2026 | https://conductscience.org/library/papers/42032299 | PubMed |
| 42010634 | Connecting HTT intermediate alleles and microRNA dysregulation to enhanced tauopathy in late-onset Alzheimer's disease. | Alzheimers Res Ther | 2026 | https://conductscience.org/library/papers/42010634 | PubMed |
| 41948730 | Hyaluronic acid: emerging roles and biomaterial innovations in Alzheimer's and Parkinson's disease therapy. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41948730 | PubMed |
| 41548010 | Differentially expressed miRNAs in the temporal cortex of Alzheimer's disease patients and their association to tau pathology. | Commun Biol | 2026 | https://conductscience.org/library/papers/41548010 | PubMed |
| 41540052 | Modeling the microRNA regulation of TGF-β/SMAD signaling pathways for seizure control in temporal lobe epilepsy. | NPJ Syst Biol Appl | 2026 | https://conductscience.org/library/papers/41540052 | PubMed |
| 41507841 | Functional significance of NLRP3 polymorphisms in mild cognitive impairment. | BMC Geriatr | 2026 | https://conductscience.org/library/papers/41507841 | PubMed |
| 41486993 | miRNAs: Promising Biomarkers for Alzheimer's Diagnosis and Treatment. | Curr Alzheimer Res | 2026 | https://conductscience.org/library/papers/41486993 | PubMed |
| 41217665 | miR-133b-3p Mitigates D-Galactose-Induced Hippocampal Neuron Aging Through Autophagy Regulation via the MAPK/ERK Signaling Pathway. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/41217665 | PubMed |
| 41216222 | Modulatory potential of A novel benzofuran-derived compound against aluminium chloride-induced neurotoxicity and miRNA dysregulation: Biochemical and bio-analytical study. | Toxicol Rep | 2025 | https://conductscience.org/library/papers/41216222 | PubMed |
| 41189611 | A plasma miRNA signature, including miR-495, as early diagnostic biomarkers associated with cognitive decline in Alzheimer's disease. | Alzheimers Dement (Amst) | 2025 | https://conductscience.org/library/papers/41189611 | PubMed |
| 40959537 | The miR-133b and miR-206 serum levels as a candidate biomarker in Alzheimer's patients with dyslipidemia. | IBRO Neurosci Rep | 2025 | https://conductscience.org/library/papers/40959537 | PubMed |
| 40943171 | Exosomal Non-Coding RNAs as Potential Biomarkers for Alzheimer's Disease: Advances and Perspectives in Translational Research. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943171 | PubMed |
| 40823947 | Common miRNAs, Genes, and Regulatory Pathways in Alzheimer's Disease and Type 2 Diabetes Mellitus: An Integrative Analysis of Systematic Reviews, Bioinformatics and Data Mining. | J Neurochem | 2025 | https://conductscience.org/library/papers/40823947 | PubMed |
| 40626247 | MicroRNAs as potential biomarkers for monitoring of acquired sensorineural hearing loss. | Pediatr Discov | 2024 | https://conductscience.org/library/papers/40626247 | PubMed |
| 40501482 | The emerging role of miRNAs in biological aging and age-related diseases. | Noncoding RNA Res | 2025 | https://conductscience.org/library/papers/40501482 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31495604
GET https://conductscience.org/api/papers/v1/31495604/cited_by?page=2